Thalidomide in the treatment of refractory cutaneous lupus erythematosus: Prognostic factors of clinical outcome

J. Cortés-Hernández, M. Torres-Salido, J. Castro-Marrero, M. Vilardell-Tarres, J. Ordi-Ros

Research output: Contribution to journalArticleResearchpeer-review

61 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Thalidomide in the treatment of refractory cutaneous lupus erythematosus: Prognostic factors of clinical outcome'. Together they form a unique fingerprint.

Medicine & Life Sciences